Lamivudine
Product Images NDC 64330-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 64330-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Centaur Pharmaceuticals Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Aeeeee8e 8f0a 4e87 Ba2a B617223889f0 01)

Chemical structure of Lamivudine showing its molecular arrangement with labeled nitrogen, oxygen, hydrogen, and sulfur atoms forming a ring and side chains.*

FDA Label Image

Image (Aeeeee8e 8f0a 4e87 Ba2a B617223889f0 02)

Line graph showing proportions of patients with HIV-1 RNA less than 400 copies/ml over 48 weeks of treatment with Lamivudine at 150 mg twice daily and 300 mg once daily. The graph compares viral suppression rates between the two dosing regimens over time.*

FDA Label Image

Container Label (Aeeeee8e 8f0a 4e87 Ba2a B617223889f0 03)

Label of Lamivudine Tablets USP 150 mg, manufactured by Centaur Pharmaceuticals Pvt. Ltd. The label indicates a package containing 60 tablets. It mentions the product is prescription only, with storage instructions and dosage information noted. The label also includes the NDC 64330-001-01 and manufacturer details in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.